Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001641172-25-016967
Filing Date
2025-06-27
Accepted
2025-06-27 17:26:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 form424b3.htm 424B3 423859
2 GRAPHIC form424b3_001.jpg GRAPHIC 16517
  Complete submission text file 0001641172-25-016967.txt   447900
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-288218 | Film No.: 251088046
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)